| Tag | Content |
|---|
EnhancerAtlas ID | HS092-30332 |
Organism | Homo sapiens |
Tissue/cell | HFF |
Coordinate | chr4:83810220-83812240 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CUX1 | MA0754.1 | chr4:83811453-83811463 | TTATCGATTA | - | 6.02 | | CUX2 | MA0755.1 | chr4:83811453-83811463 | TTATCGATTA | - | 6.02 | | IRF1 | MA0050.2 | chr4:83810699-83810720 | AAAAAAAAAAAAAAAGTAAAA | - | 6.16 | | IRF1 | MA0050.2 | chr4:83810705-83810726 | AAAAAAAAAGTAAAAGAAAAA | - | 6.89 | | RARA | MA0729.1 | chr4:83810618-83810636 | GAGCCCAAAAGTTCAAGG | + | 6.15 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_35470 | chr4:83805263-83814651 | HepG2 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AGGATTTATT TAGTATTTTC AATGTTCTAG GTTCATTTCA CTCAACCCAA ACCAAATCAA 60
AGGAGAAAGC AACTGTGCAC TGGTTACTGA ACTAATTGGT GTCATACTAA TCTTCAGTAT 120
AATAAAACTT TTTGAGCTGA AATTAACCTA ATGACATTCC TAACAACAAT GTAATCAATG 180
TAAATCAATC TAGTAATATC CCCTTACAGG AGTTTTTAAC TTGTAAACTT CATAATATTA 240
TGTATATAGA AAATCCTACA TGTCACTTGA AAGCAGGAGC TTGAGTCCAG CCTGGGGAAC 300
GCAGTGAGAC CCCCATCTCT ATAAAAAATA AGATTAGTTG GGCGTGCGCC ACGTGCATAT 360
TCCTAGCTAC TTCTGAGGCT GAGGCGGGAG GATCTCTTGA GCCCAAAAGT TCAAGGTTAT 420
AGTGAGCTAT GACTGCACCA CTGCACTCCA ATCTGGGCAA CAAAGAGGGA CCCTGTCTCA 480
AAAAAAAAAA AAAAGTAAAA GAAAAAAAAA GAAAATCCTA CATGTGTGTA TATGTGCATT 540
CTTCCAATGC TTTCATTAGA TTCCCGTAAG ACAGTGAAAT CCCCCCAAAA TTTTGAATCA 600
TTGCTCTTCA CAGTTTACAA ATTTATTTCT ATTCCCATGT TATTGGTTTC AATAAAGAAT 660
TTGCTTATAT AAAATTAAGC AATATCATTA TAAATCCACC TCAAATTTCA AATTTCACAA 720
ATAACCGCGG ACGTATTTAA GATAAAATCA CTACAAAACT ACAAAAACAC TACGAGTTAT 780
CCAAAAGTTC TTAAGAGTCT ACAAACCTCT CCCTGAGCTG TTAATTAAGG GATAGTGAGA 840
AACAAGGAGC ACAGAAGAAC CACTAAAAAA GGAGAGTAGG CTGGGCGTGG TGGCTTATGC 900
CTGTAACCCC AGCACTTCGG GAGGCCAACT CGGGCGGATC ACTTGAGGTC AGGAGTGCCA 960
GACCAGCCTG ACCAACAGCG TGAAACCCCG TCTCTACTAA AAATACAAAA ATTAGACAGG 1020
TGTGGTGGTG GGCGCCTGTA ATCCCAGCTA CTCAGGAGGC TGAGACGGAG GTTGCAGTGA 1080
GCTGAGATCG CGCCACTGCA CTCCAGCCTG GGTGACAGAG CGAGACTCCG TCTCAAAAAA 1140
AAAAAAAAAA AAAAAAAAGG AGAGTAAGCT TTTGCCAACT CTTGAATAAA CGGAGGTACA 1200
GAAAACGCAG GACGCTGTAA CAAGAACACA CCCTTATCGA TTAAATACAG TTATAACTGC 1260
CCACAAAGAC AACCAAATTT CAGTTTTCTA TAGTTAGAAA AAATAAGTTA GGAGAAAGGA 1320
TTTGTCACAG ACTATCAGAT CACTGCAACT TCAAATAGCC CTACGTAAAA TTAATTCCTT 1380
AAGCGCAAGA AAAAATTTAT AATGCCCACA AGTCCAGGCA ATATTTTGGT TTATTTTACA 1440
ACAGCCCCGT AATTTAACAA CTTATTAGCA AAAACATGTA ACACTTAATG AGACTGCCCT 1500
CAAAGTACAG GCTGCGCCTG GCTACCACCG TCCTTAAAAT AATCCTAGTT AAATGACAGT 1560
AGACGTCAGT TCAAACCTAT GAACCTTTAA ATCTGGCAAT AGTTCAAGTA CAAAAAAAAA 1620
TCCTAACCAA AGCCAAAGTA ATCCTGAGAT TTTTTTTCCT CTCCTCACCC TCGGGGACCG 1680
CACCTCTTTG TGCACAAGGG TCTGAAAGTC TCCTAATCTC AAACTCCAGT TACCAGCCCG 1740
GCTACTACTC CCCGGCAAGA CACTGTCGCC AGCCTCGGGT GGCTTTTGCT CAGCAGTGGA 1800
GACGTCGGCG AATGCGGACG GGCGCGATCA CTGGAGTCCA GATGCCAGGC GTTGTTCCGC 1860
CGGGCCCGAA ACCAAGACTA GGGGCGCGCC GTCACCAGAG ACCGGGCCTC AGGCTGGTGC 1920
GGGGCAGCGG AGACCCAGGC TGCGGTCCCA GTTTTGGCCT GGGCTCTACC TCAAAGCTTA 1980
AGGACCGGCG AAGAGGACAA AAAGCAACGG GCGGACGCAC 2020
|
